Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Radiation Injuries × Bevacizumab × Clear all

Phase

Phase 2 3 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 74 Ovarian Neoplasms 28 Carcinoma, Non-Small-Cell Lung 24 Breast Neoplasms 24 Colonic Neoplasms 20 Rectal Neoplasms 18 Neoplasms 16 Fallopian Tube Neoplasms 16 Neoplasm Metastasis 11 Carcinoma, Hepatocellular 11 Glioblastoma 10 Carcinoma, Renal Cell 7 Brain Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Lung Neoplasms 6 Uterine Cervical Neoplasms 5 Intestinal Neoplasms 5 Gastrointestinal Neoplasms 5 Digestive System Neoplasms 5 Brenner Tumor 5 Recurrence 4 Glioma 4 Rectal Diseases 3 Peritoneal Neoplasms 3 Liver Neoplasms 3 Intestinal Diseases 3 Gastrointestinal Diseases 3 Digestive System Diseases 3 Colonic Diseases 3 Carcinoma, Ovarian Epithelial 3

Interventions

Radiotherapy 5 Carboplatin 3 Paclitaxel 2 Donepezil 2 Cisplatin 2 sargramostim 1 cevimeline 1 beta Carotene 1 alpha-Tocopherol 1 Zinc Sulfate 1 Vortioxetine 1 Vitamin E 1 Standard of Care 1 Sodium Chloride 1 Salts 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiosurgery 1 Oxygen 1 Oxaliplatin 1 Meditation 1 Hyperbaric Oxygenation 1 Glutamine 1 G(M1) Ganglioside 1 Filgrastim 1 Etoposide 1 Erythropoietin 1 Epoetin Alfa 1 Dexamethasone 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06888817 2026-02-25

BRAINS

The Netherlands Cancer Institute

Phase 3 Recruiting

Brain Neoplasms, Glioma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡